Russian Ministry of Health order from 07.11.2012 N 679n
Standard specialized care for adults with acute viral hepatitis A mild
Age category: adults
Floor: any
Phase: acute
Stage: light severity
complications: regardless of the complications
Type of medical care: specialized medical care
care conditions: stationary
The form of medical care: emergency
Average treatment time (number of days): 9
Code ICD X and disease entities
B15.9 |
Acute hepatitis A |
1. Medical interventions to diagnose the disease, condition,
Reception (examination, consultation), a specialist doctor | |||
Kodmeditsinskoy services |
Name of medical services |
The average rate of frequency(1) |
The average index of the multiplicity of application |
B01.014.001 |
Reception (examination, consultation), an infectious disease physician primary |
1 |
1 |
B01.015.001 |
Reception (examination, consultation) Cardiologist Primary |
0,01 |
1 |
B01.057.001 |
Reception (examination, consultation) surgeon primary |
0,01 |
1 |
B01.058.001 |
Reception (examination, consultation) endocrinologist primary |
0,01 |
1 |
Laboratory Methods | |||
Kodmeditsinskoy services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A09.05.013 |
Determination of albumin / globulin ratio in blood |
0,2 |
1 |
A09.05.014 |
A study in blood levels of globulin fractions |
0,2 |
1 |
A12.05.027 |
Definition of the prothrombin (thromboplastin) in the blood or plasma time |
0,1 |
1 |
A12.06.011 |
Reacting Wasserman (RW) |
1 |
1 |
A26.05.011 |
Molecular biological research on blood Epstein-Barr virus (Epstein -Barr virus) |
0,01 |
1 |
A26.06.029 |
Determination of antibodies to capsid antigen of Epstein-Barr virus VCA (IgM) (diagnosis of acute infection) in the blood |
0,01 |
1 |
A26.06.034 |
Determination of antibody class M, G (IgG, IgM) to HAV (Hepatitis A virus) in blood |
1 |
1 |
A26.06.036 |
Determination of antigen to the virus hepatitis B (NBsAg Hepatitis B virus) in blood |
1 |
1 |
A26.06.041 |
Determination of antibody class M, G (IgM, IgG) to the viral hepatitis C (Hepatitis Cvirus) in the blood |
1 |
1 |
A26.06.048 |
Determination of antibody class M, G (IgM, IgG) to human immunodeficiency virus HIV-1 (Human immunodeficiency virus HIV 1) in the blood |
1 |
1 |
A26.06.049 |
Determination of antibody class M, G (IgM, IgG) to human immunodeficiency virus HIV-2 (Human immunodeficiency virus HIV 2) in the blood |
1 |
1 |
A26.06.054 |
Determination of antibodies to Leptospira interrogans (Leptospira interrogans) Blood |
0,01 |
1 |
A26.06.090 |
Determination of antibodies to the virus of hemorrhagic fever with renal syndrome blood |
0,01 |
1 |
B03.016.003 |
Total (clinical) blood test detailed |
1 |
1 |
B03.016.004 |
Biochemical analysis of blood Obshcheterapevtichesky |
1 |
1 |
B03.016.006 |
Urinalysis total |
1 |
1 |
Instrumental methods of research | |||
Kodmeditsinskoy services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A04.16.001 |
Ultrasound examination of the abdominal cavity (complex) |
1 |
1 |
A05.10.006 |
electrocardiogram |
1 |
1 |
A06.09.006.001 |
Lung digital fluorography |
1 |
1 |
2. Medical services for the treatment of diseases, conditions and monitor treatment
Reception (examination, consultation) and specialist doctor supervision | |||
Code of medical services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
B01.014.003 |
Daily inspection infectious disease with the supervision and care of middle and junior medical staff in a hospital ward |
1 |
8 |
Laboratory Methods | |||
Kodmeditsinskoy services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
B03.016.003 |
Total (clinical) blood test detailed |
1 |
2 |
B03.016.004 |
Biochemical analysis of blood Obshcheterapevtichesky |
1 |
3 |
B03.016.006 |
Urinalysis total |
1 |
2 |
Instrumental methods of research | |||
Kodmeditsinskoy services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A04.16.001 |
Ultrasound examination of the abdominal cavity (complex) |
0,1 |
1 |
A05.10.006 |
electrocardiogram |
0,01 |
1 |
A06.09.007 |
radiography |
0,01 |
1 |
Other research methods | |||
Kodmeditsinskoy services |
Name of medical services |
The average rate of frequency |
The average index of the multiplicity of application |
A03.16.001 |
Esophagogastroduodenoscopy |
0,001 |
1 |
3. The list of drugs for medical use, registered on the territory of the Russian Federation, with an indication of the mean daily dose courses
The code |
Anatomical Therapeutic Chemical Classification System |
Name of the drug ** |
The average rate of frequency |
Units |
SSD *** |
SKD **** |
|---|---|---|---|---|---|---|
A03AA |
Synthetic anticholinergics, esters with tertiary amino group |
0,1 |
||||
platifillin |
mg |
2 |
10 |
|||
A03AD |
Papaverine and its derivatives |
0,4 |
||||
Drotaverinum |
mg |
160 |
1600 |
|||
A05BA |
Preparations for the treatment of liver diseases |
0,1 |
||||
Glycyrrhizic acid + Phospholipids |
mg |
500 |
2500 |
|||
A06AD |
Osmotic laxatives |
0,2 |
||||
lactulose |
ml |
45 |
225 |
|||
A07BA |
coal preparations |
0,5 |
||||
Activated carbon |
mg |
10000 |
50000 |
|||
A07BC |
Absorbent intestinal drugs other |
0,1 |
||||
dioctahedral smectite |
g |
9 |
45 |
|||
A11GA |
Ascorbic acid (vitamin C) |
0,5 |
||||
Vitamin C |
mg |
100 |
1000 |
|||
B05XA |
electrolyte solutions |
1 |
||||
potassium chloride |
mg |
4000 |
20000 |
|||
Sodium chloride |
ml |
500 |
5000 |
|||
magnesium sulfate |
mg |
2500 |
25000 |
|||
C04AD |
purine derivatives |
0,05 |
||||
pentoxifylline |
mg |
100 |
300 |
|||
L03AX |
other immunostimulants |
0,667 |
||||
meglumine akridonatsetat |
mg |
2500 |
25000 |
|||
meglumine akridonatsetat |
mg |
600 |
3000 |
|||
N07XX |
Other drugs for the treatment of nervous system diseases |
0,1 |
||||
|
Inosine + nicotinamide + Riboflavin + succinic acid |
ml |
10 |
30 |
|||
R03DA |
xanthine |
0,2 |
||||
aminophylline |
mg |
240 |
1200 |
|||
V03AB |
antidotes |
0,05 |
||||
sodium thiosulfate |
mg |
3000 |
9000 |
|||
V07AB |
Solvents and diluents, including irrigation solutions |
1 |
||||
Water for injections |
ml |
20 |
400 |
* - International Statistical Classification of Diseases and Related Health X review
** - international nonproprietary or chemical name of the drug, and in their absence - the trade name of the drug
*** - average daily dose
**** - average course dose
Remarks:
1. Medicinal products for medical use, registered on the territory of the Russian Federation shall be appointed in accordance with the instructions for use of the drug for medical use and for pharmacotherapeutic group Anatomical Therapeutic Chemical Classification System, recommended by the World Health Organization, as well as the route of administration and application of the drug.
2. Purpose and use of drugs for medical use, medical devices and specialized clinical nutrition products are not included in the standard of care, allowed in the case of medical indications (individual intolerance, for health reasons) by the decision of the medical commission (Part 5 of Article 37 of the Federal Law of November 21, 2011 № 323-FZ "On the basis of public health protection in the Russian Federation" (Collected Legislation of the Russian Federation, 2011, № 48, Art. 6724; 2012, number 26, Art. 3442, 3446)).
(1)the likelihood of providing medical services or prescribing for medical applications (medical devices) included in the standard of care that can take values from 0 to 1, where 1 indicates that the event is 100% of patients true to the model, and the figures at least 1 - indicated in the medical care of patients the standard percentage, with appropriate medical readings.
